Skip to main content
Skip to main content
TCAC logo

Tuatara Capital Acquisition Corporation (TCAC) Stock Analysis

DELISTED 2022

What happened to Tuatara Capital Acquisition Corporation (TCAC) stock?

Tuatara Capital Acquisition Corporation (TCAC) no longer trades on public markets. It was delisted in June 2022. The figures below are historical and are not a current quote.

Vol: 70.9K| 52-wk range: $8.30 – $9.38
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Tuatara Capital Acquisition Corporation (TCAC) trades at $8.55. Tuatara Capital Acquisition Corporation is a special purpose acquisition company (SPAC) focused on the cannabis industry. Sector: Financial services.

Last analyzed: Mar 18, 2026
Tuatara Capital Acquisition Corporation is a special purpose acquisition company (SPAC) focused on the cannabis industry. The company aims to identify and merge with a business in the cannabis sector, seeking to create shareholder value through the combination.

Analyst Coverage for TCAC: TCAC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TCAC against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the TCAC film Every key number, told as a short cinematic story — just press play. ~2 min

Tuatara Capital Acquisition Corporation (TCAC) Financial Services Profile

CEOAlbert J. Foreman
HeadquartersNew York City, US
IPO Year2021

Tuatara Capital Acquisition Corporation, a special purpose acquisition company (SPAC), targets the cannabis industry for a potential merger, capital stock exchange, or asset acquisition. Incorporated in 2020, the company seeks to capitalize on opportunities within the evolving cannabis market landscape, but faces risks inherent in SPAC structures and regulatory uncertainties.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for TCAC?

As of Mar 18, 2026 — figures reflect the data available on that date.

Tuatara Capital Acquisition Corporation presents a speculative investment opportunity tied to its ability to successfully merge with a promising cannabis business. The company's value is contingent on identifying a target with strong growth potential and executing a transaction that is accretive to shareholder value. Key considerations include the valuation of the target company, the regulatory environment for cannabis businesses, and the competitive landscape. The negative P/E ratio of -22.86 and negative profit margin of -40.8% reflect the company's current status as a SPAC without operational revenue. A successful merger could lead to significant upside, but the risk of failing to complete a transaction or merging with an underperforming business is substantial. Investors should carefully assess the management team's expertise and track record in evaluating and executing acquisitions.

Based on FMP financials and quantitative analysis

TCAC Key Highlights

Tuatara Capital Acquisition Corporation operates as a special purpose acquisition company (SPAC) targeting the cannabis industry.

  • The company's gross margin is 73.5%, reflecting potential profitability upon successful business combination.
  • The company has a negative P/E ratio of -22.86, indicating it is currently not profitable.
  • Tuatara Capital Acquisition Corporation has no dividend yield, as it is not currently generating revenue.
  • The company's focus is on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in cannabis industry.

Who Are TCAC's Competitors?

TCAC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
BIOS BioPlus Acquisition Corp. $10.79 -0.05% $209M 44
BOAC Bluescape Opportunities Acquisition Corp. $10.02 -0.09% $226M 46
BSAQ Black Spade Acquisition Co $10.45 -29.49% $221M 44
COEP Coeptis Therapeutics, Inc. $10.99 -8.57% $38.6M 31
JUGG Jaws Juggernaut Acquisition Corporation $10.33 -0.10% $356M 44
AGGI Allied Energy, Inc. $2.25 +32.24% $45.4B 61
GSHN Gushen, Inc. $22.70 +2.71% $9.32B 61
IVAN Ivanhoe Capital Acquisition Corp. $7.68 -2.17% $2.69B 64

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TCAC's Key Strengths?

Dedicated focus on the cannabis industry.

  • Experienced management team with expertise in finance and cannabis.
  • Access to capital raised through the IPO.
  • Opportunity to create value through a successful business combination.

What Are TCAC's Weaknesses?

Lack of operating history and revenue.

  • Dependence on identifying and completing a suitable business combination.
  • Competition from other SPACs and private equity firms.
  • Regulatory uncertainties surrounding the cannabis industry.

What Could Drive TCAC Stock Higher?

TCAC catalyst: Announcement of a definitive agreement to merge with a target company in the cannabis industry.

  • Completion of the business combination, resulting in the target company becoming publicly traded.
  • Continued growth and expansion of the cannabis market.
  • Potential for regulatory changes that could benefit cannabis businesses.

What Are the Key Risks for TCAC?

Failure to identify and complete a suitable business combination.

  • Overvaluation of the target company, leading to poor returns for shareholders.
  • Regulatory risks and uncertainties surrounding the cannabis industry.
  • Competition from other SPACs and established cannabis companies.
  • Economic downturn that could negatively impact the cannabis industry.

What Are the Growth Opportunities for TCAC?

  • Growth opportunity 1: Successful Acquisition of a High-Growth Cannabis Business: Tuatara Capital Acquisition Corporation's primary growth opportunity lies in identifying and acquiring a high-growth cannabis business with strong fundamentals and a clear path to profitability. The global cannabis market is projected to reach $47.2 billion by 2027, presenting a significant opportunity for companies operating in this space. A successful acquisition could provide Tuatara Capital Acquisition Corporation with exposure to this rapidly growing market and generate significant returns for its shareholders. The timeline for this growth opportunity is dependent on the company's ability to identify and complete a suitable transaction, which could occur within the next 12-24 months.
  • Growth opportunity 2: Expansion into New Cannabis Markets: Following a successful business combination, Tuatara Capital Acquisition Corporation could pursue growth by expanding into new cannabis markets, both domestically and internationally. The legalization of cannabis is spreading to new jurisdictions, creating opportunities for companies to enter these markets and capture market share. This expansion could involve establishing new operations, acquiring existing businesses, or forming strategic partnerships. The timeline for this growth opportunity is dependent on regulatory developments and market conditions, but could begin within the next 2-3 years.
  • Growth opportunity 3: Development of Innovative Cannabis Products and Services: Tuatara Capital Acquisition Corporation could drive growth by investing in the development of innovative cannabis products and services that meet the evolving needs of consumers. This could include new strains of cannabis, novel delivery methods, or technology-enabled solutions for the cannabis industry. By developing differentiated products and services, the company could gain a competitive advantage and attract new customers. The timeline for this growth opportunity is dependent on research and development efforts and regulatory approvals, but could begin within the next 1-2 years.
  • Growth opportunity 4: Strategic Partnerships and Alliances: Tuatara Capital Acquisition Corporation could pursue growth by forming strategic partnerships and alliances with other companies in the cannabis industry. This could include partnerships with cultivators, processors, distributors, or retailers. These partnerships could provide access to new markets, technologies, or distribution channels. The timeline for this growth opportunity is dependent on identifying suitable partners and negotiating mutually beneficial agreements, but could begin within the next 6-12 months.
  • Growth opportunity 5: Capitalizing on Regulatory Changes: As the regulatory landscape for cannabis evolves, Tuatara Capital Acquisition Corporation could capitalize on these changes to drive growth. This could involve entering new markets that have recently legalized cannabis, or taking advantage of new regulations that create opportunities for cannabis businesses. The timeline for this growth opportunity is dependent on regulatory developments, but could occur within the next 1-3 years.

What Opportunities Does TCAC Have?

  • Rapid growth of the cannabis market.
  • Increasing acceptance of cannabis for medicinal and recreational use.
  • Potential for regulatory changes that could benefit cannabis businesses.
  • Opportunity to consolidate the fragmented cannabis industry.

What Are TCAC's Competitive Advantages?

  • Tuatara Capital Acquisition Corporation's moat is limited due to the nature of SPACs.
  • The management team's expertise and network in the cannabis industry could provide a competitive advantage.
  • Early mover advantage in identifying and securing a promising target company.

What Does TCAC Do?

Tuatara Capital Acquisition Corporation, established in 2020 and based in New York City, operates as a special purpose acquisition company (SPAC). Its primary objective is to identify and complete a business combination, such as a merger, capital stock exchange, asset acquisition, stock purchase, or reorganization, with one or more businesses operating within the cannabis industry. As a SPAC, Tuatara Capital Acquisition Corporation does not have any operating history or generate revenue from operations until it completes an initial business combination. The company was formed to take advantage of opportunities within the rapidly evolving cannabis market, which includes both medicinal and recreational cannabis businesses. The company's strategy involves leveraging the expertise of its management team to identify promising cannabis businesses that could benefit from becoming publicly traded. The process typically involves extensive due diligence, negotiation of terms, and shareholder approval. Upon completion of a business combination, the target company becomes a publicly traded entity, and Tuatara Capital Acquisition Corporation's shareholders receive shares in the combined company. The success of Tuatara Capital Acquisition Corporation depends on its ability to identify and complete a suitable business combination that creates value for its shareholders. The company faces competition from other SPACs and private equity firms seeking to invest in the cannabis industry.

What Products and Services Does TCAC Offer?

  • Tuatara Capital Acquisition Corporation is a special purpose acquisition company (SPAC).
  • The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, or reorganization.
  • It targets businesses within the cannabis industry.
  • The company seeks to identify and combine with one or more cannabis-related businesses.
  • Tuatara Capital Acquisition Corporation aims to create value for its shareholders through a successful business combination.
  • It provides a pathway for private cannabis companies to become publicly traded.

How Does TCAC Make Money?

  • Tuatara Capital Acquisition Corporation raises capital through an initial public offering (IPO).
  • The company seeks to identify and merge with a private cannabis company.
  • Upon completion of a business combination, the target company becomes publicly traded, and Tuatara Capital Acquisition Corporation's shareholders receive shares in the combined company.

What Industry Does TCAC Operate In?

Tuatara Capital Acquisition Corporation operates within the shell companies industry, specifically as a SPAC focused on the cannabis sector. The cannabis industry is characterized by rapid growth, evolving regulations, and increasing acceptance of both medicinal and recreational use. SPACs have become a popular vehicle for cannabis companies to go public, providing access to capital and a faster route to the public markets compared to traditional IPOs. However, the SPAC market is highly competitive, and the success of a SPAC depends on its ability to identify and complete a value-creating acquisition. The regulatory landscape for cannabis businesses is complex and varies by jurisdiction, creating both opportunities and challenges for SPACs operating in this space.

Who Are TCAC's Key Customers?

  • Tuatara Capital Acquisition Corporation's 'customers' are the investors who purchase shares in its IPO.
  • The company also serves as a vehicle for private cannabis companies seeking to go public.
  • Ultimately, the combined company serves customers in the cannabis market.
AI Confidence: 79% Updated: Mar 18, 2026

Company Profile

Tuatara Capital Acquisition Corporation operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Albert J. Foreman. TCAC has traded publicly since 2021.

ROE 25%

Key Financial Metrics

Return on equity for Tuatara Capital Acquisition Corporation stands at 25.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -69.9%, showing how much profit it generates from its asset base. A current ratio of 0.23 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.7%, the inverse of the P/E and a quick read on earnings relative to price.

TCAC Financials

Fundamental Snapshot

Revenue Growth (FY)
-7.4%
Net Income Growth (FY)
-73.1%
EPS Growth (FY)
-75.0%
Free Cash Flow Growth (FY)
+131.6%
Return on Equity (TTM)
+25.1%
Current Ratio
0.2

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Dedicated focus on the cannabis industry.
  • Experienced management team with expertise in finance and cannabis.
  • Access to capital raised through the IPO.
  • Opportunity to create value through a successful business combination.

Bear Case

  • Lack of operating history and revenue.
  • Dependence on identifying and completing a suitable business combination.
  • Competition from other SPACs and private equity firms.
  • Regulatory uncertainties surrounding the cannabis industry.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

TCAC Latest News

No recent news available for TCAC.

Leadership: Albert J. Foreman

CEO

Albert J. Foreman serves as the CEO of Tuatara Capital Acquisition Corporation. His background includes extensive experience in finance and investment management. Prior to joining Tuatara Capital Acquisition Corporation, Mr. Foreman held various leadership positions at investment firms, where he focused on identifying and investing in emerging growth companies. He has a strong track record of creating value for shareholders through strategic investments and acquisitions. Mr. Foreman holds a degree in finance from a leading business school.

Track Record: Under Mr. Foreman's leadership, Tuatara Capital Acquisition Corporation has focused on identifying potential merger targets within the cannabis industry. His strategic decisions have been centered around thorough due diligence and seeking opportunities with high growth potential. The company's efforts are ongoing to secure a business combination that aligns with its investment objectives.

What Investors Ask About Tuatara Capital Acquisition Corporation (TCAC) — Financial Services

What happened to Tuatara Capital Acquisition Corporation (TCAC) stock?

Tuatara Capital Acquisition Corporation (TCAC) no longer trades on public markets. It was delisted in June 2022. The figures below are historical and are not a current quote.

Can I still buy TCAC shares?

No. TCAC stopped trading on public markets in June 2022, so the shares are not available through a broker. Anything you see quoted for TCAC elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before TCAC stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Tuatara Capital Acquisition Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Tuatara Capital Acquisition Corporation do?

Tuatara Capital Acquisition Corporation is a special purpose acquisition company (SPAC) focused on the cannabis industry. It does not have any operations of its own but was formed to raise capital through an initial public offering (IPO) for the purpose of acquiring or merging with one or more operating cannabis businesses.

What do analysts say about TCAC stock?

As of 2026-03-18, there is no readily available analyst consensus on Tuatara Capital Acquisition Corporation (TCAC), likely due to its nature as a SPAC prior to completing a merger. Valuation metrics are not meaningful at this stage, as the company's financial performance is dependent on the target company it ultimately acquires.

What are the main risks for TCAC?

The main risks for Tuatara Capital Acquisition Corporation include the risk of failing to identify and complete a suitable business combination within the allotted timeframe, which could result in the liquidation of the company and the return of capital to shareholders. There is also the risk of overpaying for a target company, which could lead to poor returns for investors.

What regulatory challenges does Tuatara Capital Acquisition Corporation face?

Tuatara Capital Acquisition Corporation faces regulatory challenges inherent in the cannabis industry, which is subject to varying and often conflicting regulations at the federal, state, and local levels. These regulations can impact the company's ability to operate, raise capital, and expand into new markets.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • AI analysis is pending for TCAC, which may provide additional insights.
  • The information provided is based on publicly available sources and may be subject to change.
Data Sources

Popular Stocks

More Stocks We Cover